<p id="79lld"><mark id="79lld"></mark></p><address id="79lld"><nobr id="79lld"></nobr></address>
<form id="79lld"></form>

    <form id="79lld"></form>

    <address id="79lld"><form id="79lld"><meter id="79lld"></meter></form></address>
    <form id="79lld"><listing id="79lld"></listing></form>

    We've updated our Privacy Policy to make it clearer how we use your personal data.

    We use cookies to provide you with a better experience, read our Cookie Policy

    Advertisement

    Industry Insights

    Ensuring Data Integrity Compliance in Pharma with CDS Software
    Industry Insight

    Data integrity is fundamental to drug development and manufacturing but can be difficult to achieve for drug developers and manufacturers who have to navigate strict data integrity guidelines provided by regulatory authorities and find effective ways to attain compliance.

    Read More

    The Future of Sustainable HPC
    Industry Insight

    It is an unavoidable fact that high-performance computing (HPC) is an energy-intensive environment. In this Insight, OCF's Mischa van Kesteren investigates the steps we can take to address this and achieve a more sustainable future for HPC.

    Read More

    Cell and Gene Therapy Manufacturing: Achieving Consistency and Reducing Variability
    Industry Insight

    Cell and gene therapies first gained regulatory approval in 2017 by the US Food and Drug Administration (FDA). Several more therapies have since been developed, and there are now 18 approved to treat a variety of diseases Technology Networks recently had the pleasure of speaking with experts at Bio-Techne to learn more about the cell and gene therapy manufacturing process.

    Read More

    Make Data Work for You in the Race To Manufacture Effective Vaccines
    Industry Insight

    It’s imperative that scientists and leaders in the COVID-19 vaccine development space have good data management practices to ensure the quality of data and to recue the time-to-market now, and in the future. In this article, we explore how to make data work for you when manufacturing an effective vaccine.

    Read More

    Addressing Key Challenges in Cell and Gene Therapy Manufacturing
    Industry Insight

    Technology Networks spoke with Hugh H. Tansey, senior director of innovation and growth programs for laboratory equipment at Thermo Fisher Scientific to learn more about how the CTS Series Laboratory Equipment can deliver solutions for the key challenges in cell and gene therapy manufacturing.

    Read More

    Leading the Charge in the Cryo-EM Resolution Revolution
    Industry Insight

    See how cryo-EM advances are changing scientific research, particularly in cell and drug discovery studies, and the role that precision instruments are playing in this.

    Read More

    Accelerated Screen Identifies 25 Existing Drugs Capable of Disrupting SARS-CoV-2 Cell Entry
    Industry Insight

    A team from the National Center for Advancing Translational Sciences (NCATS) has screened existing drug compounds that have already passed through the entire drug development pipeline, to determine if any can disrupt the interaction between the SARS-CoV-2 spike protein and the host’s angiotensin converting enzyme 2 (ACE2) receptor.

    Read More

    Advanced Cell Screening and Imaging Reveals How the Cardiac System Responds in Drug Development
    Industry Insight

    In drug discovery, time and monetary investments increase significantly the further candidates advance through the preclinical phase of testing, analysis and evaluation. By excluding non-viable compounds for safety and toxicity reasons early on, resources can be redirected to bring the most promising drugs to market sooner.

    Read More

    Looking Beyond the Spike Protein for SARS-CoV-2 Vaccine Design
    Industry Insight

    Biotech company COVAXX is developing a COVID-19 vaccine using a multi-antigen peptide platform, which not only targets the infamous SARS-CoV-2 Spike (S) protein but also targets other parts of the virus to enhance the immune response. Technology Networks spoke with Mei Mei Hu, co-founder of COVAXX, to learn more about the vaccine platform and the preclinical data that has been obtained for UB-612.

    Read More

    Antiviral Conjugates – A Novel Treatment and Prevention Strategy for Viral Diseases Including COVID-19
    Industry Insight

    Infectious diseases remain a major health threat. The ongoing evolution of viral variants makes it likely that emerging infections will continue to occur – highlighting the need to develop new therapeutic and preventive approaches. Jeff Stein, PhD, President and CEO at Cidara Therapeutics tells Technology Networks more about a novel antiviral strategy they have developed called antiviral conjugates.

    Read More

     
    Advertisement
     
    王中王中特免费公开资料选料